コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eletion of part or all of the ribose operon (rbs genes).
2 artificial chromosome containing most of the Rb gene.
3 elegans mutants lacking a functional lin-35 RB gene.
4 both specific and overlapping functions with RB gene.
5 omas invariably have somatic mutation in the RB gene.
6 to assess for loss of heterozygosity of the rb gene.
7 old in patients who inherit mutations in the RB gene.
8 ated RB phosphorylation, and mutation of the RB gene.
9 of wild-type p16(INK4A) on expression of the RB gene.
10 ting that each of these tumors had an intact RB gene.
11 ells that have one deleted and one truncated RB gene.
12 nduced transcriptional downregulation of the RB gene.
13 t p130 is related to, yet distinct from, the RB gene.
14 h inactivation of the ubiquitously expressed Rb gene.
15 act on their invasiveness as compared to the RB gene.
16 is known about developmentally regulated E2F/RB genes.
17 a targeted disruption of the retinoblastoma (Rb) gene.
18 of the six GBMs without either CDKN2/p16 or RB gene abnormalities, one case had CDK4 gene amplificat
19 Indeed, genetic ablation of the p27(Kip1) or Rb genes accentuated Tag-induced tumorigenesis, with los
20 16 alterations, none had allelic loss of the RB gene and all expressed pRb, suggesting that each of t
21 pical cells contain no wild-type copy of the Rb gene and synchronously form early atypical proliferat
23 lidate our approach by targeting the p53 and Rb genes and establishing cell line and in vivo cancer m
24 ccess is owed to deciphering the role of the Rb gene, and the benefits of targeted therapies, such as
28 CDK4 amplification, and allelic loss of the RB gene, as well as for expression of p16 and pRb protei
29 1 suppression is independent of the p53 and Rb genes, but requires an intact TGF-beta type II recept
31 the selective growth advantage conferred by Rb gene deletion during tumorigenesis may be explained i
32 recognizes the protein product of the medaka Rb gene, detecting a 105 kDa protein in all tissues exam
36 scriptional activation and repression by the Rb gene family has been extensively investigated: pRb, p
37 E2f activity, following inactivation of the Rb gene family in a mouse model of liver cancer, initial
39 exit following DNA damage induction, and how Rb gene family's interaction with chromatin remodeling f
40 essors of the retinoblastoma susceptibility (Rb) gene family, we have previously shown that activatio
43 etinoblastoma protein (pRB) and mutations of RB gene have been reported in up to 70% of MM patients a
45 itu hybridization showed allelic loss of the rb gene in 10 (40%) of 25 tumors analyzed and was signif
46 er we analysed the protein expression of the RB gene in cell lines obtained from 83 patients with sma
48 population, by conditionally disrupting the RB gene in neurogenin3 (Ngn3)-expressing cells in both p
49 ineage-specific character of retinoblastoma (Rb) gene inactivation during tumor formation, the earlie
51 Z/EG reporter, as well as the floxed p53 and Rb genes, into irradiated p53loxP/loxPRbloxP/loxP mice,
53 arental allele of the murine retinoblastoma (Rb) gene is sufficient for spontaneous melanotroph carci
57 lelic loss of chromosome 13q at the RB gene, RB gene mutations, or loss of pRb expression was noted i
59 Fibroblasts prepared from retinoblastoma (Rb) gene-negative mouse embryos exhibit a shorter G1 pha
60 ctivate the anthocyanin pathway, whereas the Rb gene, of undetermined function, maps to chromosome 1.
61 B is directly inactivated by mutation in the RB gene or functionally inhibited by abnormal activation
62 pression of dominant-negative mutants of the Rb gene, or the transcription factor E2F-1, which is a d
63 only provides an opportunity to analyze the Rb gene pathway in the development and progression of pr
74 d in cervical cancer cell lines in which the RB gene, Rb, is not functional, either as a consequence
75 nding mature melanotrophs with the wild-type Rb gene, Rb-negative cells in EAP continue to proliferat
76 These results support the concept that the Rb gene regulatory network (GRN) subcircuit that regulat
78 tastasis suppressor, SSeCKS/Gravin/AKAP12 or Rb, genes that are downregulated or deleted in human pro
79 harboring loxP sites flanking exon 3 of the Rb gene to delineate the action of RB in the chemotherap
83 inations of normal and mutated p16, p53, and Rb genes via a recombinant adenovirus to determine the e
87 B), p16(INK4A), p14(ARF) and retinoblastoma (RB) genes was studied using methylation specific polymer